California Public Employees Retirement System maintained its position in AxoGen, Inc. (NASDAQ:AXGN) during the first quarter, Holdings Channel reports. The firm owned 105,200 shares of the medical equipment provider’s stock at the end of the first quarter. California Public Employees Retirement System’s holdings in AxoGen were worth $1,099,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Parametric Portfolio Associates LLC raised its position in AxoGen by 0.9% in the first quarter. Parametric Portfolio Associates LLC now owns 10,843 shares of the medical equipment provider’s stock valued at $113,000 after buying an additional 93 shares during the last quarter. Campbell & CO Investment Adviser LLC increased its position in shares of AxoGen by 3.2% in the first quarter. Campbell & CO Investment Adviser LLC now owns 11,055 shares of the medical equipment provider’s stock worth $116,000 after buying an additional 341 shares in the last quarter. TFS Capital LLC purchased a new position in shares of AxoGen during the first quarter worth about $120,000. SG Americas Securities LLC purchased a new position in shares of AxoGen during the first quarter worth about $150,000. Finally, American International Group Inc. increased its position in shares of AxoGen by 7.7% in the first quarter. American International Group Inc. now owns 14,941 shares of the medical equipment provider’s stock worth $156,000 after buying an additional 1,068 shares in the last quarter. 64.58% of the stock is owned by institutional investors and hedge funds.
Shares of AxoGen, Inc. (AXGN) traded up 0.66% on Friday, reaching $15.15. 9,371 shares of the company were exchanged. The stock’s market capitalization is $503.59 million. AxoGen, Inc. has a 1-year low of $7.65 and a 1-year high of $17.25. The company has a 50-day moving average price of $15.86 and a 200 day moving average price of $12.87.
AxoGen (NASDAQ:AXGN) last released its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported ($0.06) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.08) by $0.02. The firm had revenue of $15.20 million during the quarter, compared to analysts’ expectations of $14.40 million. AxoGen had a negative return on equity of 114.64% and a negative net margin of 27.50%. AxoGen’s quarterly revenue was up 46.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.09) EPS. On average, analysts forecast that AxoGen, Inc. will post ($0.31) EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “California Public Employees Retirement System Maintains Stake in AxoGen, Inc. (AXGN)” was published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/08/11/california-public-employees-retirement-system-maintains-stake-in-axogen-inc-axgn.html.
A number of research analysts recently issued reports on the stock. BidaskClub downgraded shares of AxoGen from a “buy” rating to a “hold” rating in a research note on Thursday, August 3rd. Leerink Swann assumed coverage on shares of AxoGen in a research note on Monday, July 31st. They issued an “outperform” rating and a $22.00 price target for the company. Wedbush reiterated an “outperform” rating and issued a $14.00 price target (down previously from $17.00) on shares of AxoGen in a research note on Friday, May 19th. Cantor Fitzgerald assumed coverage on shares of AxoGen in a research note on Thursday, June 29th. They issued an “overweight” rating and a $18.00 price target for the company. Finally, ValuEngine upgraded shares of AxoGen from a “sell” rating to a “hold” rating in a research note on Friday, June 2nd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Buy” and a consensus price target of $15.90.
Want to see what other hedge funds are holding AXGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AxoGen, Inc. (NASDAQ:AXGN).
What are top analysts saying about AxoGen Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AxoGen Inc. and related companies.